Difference between revisions of "Duloxetine-amitriptyline"
From Psychiatrienet
| Line 3: | Line 3: | ||
| to = amitriptyline | | to = amitriptyline | ||
| stop = | | stop = | ||
| − | {{ | + | {{TCAdecrease25p3d}} |
| start = | | start = | ||
| − | + | {{TCAincrease25p3d}} | |
| − | + | | info = | |
| − | | info = | + | {{TCAplasmalevelmonitoring}} |
| − | |||
| − | |||
Revision as of 13:48, 30 June 2023
{{Drugswitch | from = duloxetine | to = amitriptyline | stop =
- Day 1: Decrease with about 25% of the original dose per 3 days.
| start =
- Day 1: Increase with about 25% of target dose per 3 days.
| info =
- Plasma monitoring for TCA's is advisable, because of plasma-reponse relations, genetic polymorphism and under or overdosing.[1]
